| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,081 |
6,659 |
$449K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,008 |
3,735 |
$209K |
| 36415 |
Collection of venous blood by venipuncture |
845 |
807 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18 |
16 |
$2K |
| 99215 |
Prolong outpt/office vis |
40 |
38 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
98 |
51 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$1K |
| 87428 |
|
15 |
13 |
$770.56 |
| 85027 |
|
149 |
146 |
$644.72 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$430.76 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
64 |
63 |
$406.93 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
29 |
27 |
$329.83 |
| 99441 |
|
13 |
13 |
$182.58 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$84.57 |
| 81001 |
|
34 |
34 |
$75.24 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
72 |
64 |
$0.00 |